![](/wp-content/uploads/2024/06/Screenshot-2024-06-06-at-1.31.39%E2%80%AFPM.png)
$599
Madrigal and Sagimet Present MASH Data at EASL 2024
Two cardiometabolic-related news items have been observed: Madrigal Pharmaceuticals announced new Rezdiffra MASH data at the EASL 2024 conference (view press release); and Sagimet Biosciences presented Ph2b FASCINATE-2 denifanstat data at the EASL 2024 conference (view press release). Below, FENIX provides highlights and insights into the respective news items.